Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Ранг среди акций #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Цена акции
$152.37
Рыночная капитализация
$376.33B
Изменение (1 день)
12.46%
Изменение (1 год)
79.41%
Страна
US
Торговля Merck & Co., Inc. (MRK)

Категория

Операционная маржа для Merck & Co., Inc. (MRK)
Операционная маржа на August 2026 TTM: 16.65%
Согласно последним финансовым отчетам и цене акций Merck & Co., Inc., текущая операционная маржа (TTM) составляет 16.65%. В конце 2024 она составила 31.51%.
История операционной маржи Merck & Co., Inc. с 2000 по 2026
Операционная маржа на конец каждого года
Год Операционная маржа Изменить
2026 (TTM) 16.65% -59.58%
2025 41.19% 30.72%
2024 31.51% 541.75%
2023 4.91% -84.08%
2022 30.84% 13.80%
2021 27.10% 102.84%
2020 13.36% -34.06%
2019 20.26% -4.07%
2018 21.12% 24.68%
2017 16.94% 22.66%
2016 13.81% -27.73%
2015 19.11% 20.80%
2014 15.82% -9.13%
2013 17.41% -16.70%
2012 20.90% 11.88%
2011 18.68% 155.89%
2010 7.30% -50.20%
2009 14.66% -42.53%
2008 25.51% 9.86%
2007 23.22% 42.54%
2006 16.29% -38.81%
2005 26.62% -9.52%
2004 29.42% -22.80%
2003 38.11% -10.08%
2002 42.38% -3.18%
2001 43.77% 94.36%
2000 22.52% 0.00%
Операционная маржа для аналогичных компаний или конкурентов
Компания Операционная маржа Разница в операционной марже Страна
43.92% -97.36%
US
26.81% -98.39%
US
29.32% -98.24%
US
26.59% -98.40%
CH
31.24% -98.12%
CH
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.